Philippe Msika
65Patents
8h-index
41Co-inventors
78Inventor score
Filing activity: Sep 15, 1997 → Sep 24, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6146616A | Antioxidant and/or antielastase composition based on lupine oil | Human Necessities | 28 | Expired |
| US5939054A | Sunscreen compositions comprising a mixture of titanium and/or zinc oxide particles, method of preparing the same and use thereof | Human Necessities | 21 | Expired |
| US7589121B2 | Use of furan alkyls for preparing a drug for treating obesity and cosmetically treating overweight | Human Necessities | 10 | Expired |
| US5869031A | Depigmenting dermatological and/or cosmetic composition | Human Necessities | 10 | Expired |
| US7897579B2 | Use of a compound comprising D-mannoheptulose and/or perseitol for treating and preventing innate immunity modification diseases | Human Necessities | 10 | Expired |
| US9089576B2 | Medicament comprising a peptide extract of avocado, which is intended for the treatment and prevention of illnesses that are linked to an immune system deficiency or oxidative stress or skin ageing or dry skin | Human Necessities | 8 | Active |
| US7816547B2 | Process for producing refined avocado oil rich in triglycerides, and oil obtainable by said process | Human Necessities | 8 | Active |
| US9023810B2 | Use of a compound comprising D-mannoheptulose and/or perseitol for treating and preventing innate immunity modification diseases | Human Necessities | 8 | Active |
| US8349377B2 | Medicament comprising a peptide extract of avocado, which is intended for the treatment and prevention of illnesses that are linked to an immune system deficiency | Human Necessities | 8 | Active |
| US7833554B2 | Medicament comprising a peptide extract of avocado, which is intended for the treatment and prevention of illnesses that are linked to an immune system deficiency | Human Necessities | 8 | Active |
| US9422504B2 | Use of whole soft avocados for preparing avocado oil rich in unsaponifiables | Chemistry; Metallurgy | 6 | Active |
| US7029713B2 | Peptide extract of lupine and pharmaceutical or cosmetic or nutritional composition comprising the same | Human Necessities | 6 | Expired |
| US8147883B1 | Use of a plant oil product as an agent for increasing the synthesis of skin lipids | Human Necessities | 5 | Expired |
| US7238377B2 | Use of an oil of the gourd family for inhibiting 5 alpha-reductase activity | Human Necessities | 5 | Expired |
| US6919071B2 | Sunscreen milk | Human Necessities | 5 | Expired |
| US7883729B2 | Natural vegetable oil concentrated in unsaponifiable matters as food ingredient | Human Necessities | 3 | Expired |
| US8318186B2 | Use of at least a fatty ester for preparing a composition designed to inhibit 5-α-reductase activity, in pharmacology, in particular dermatology, in cosmetics and as food additive | Human Necessities | 3 | Expired |
| US7638149B2 | Peptide extract of lupine and pharmaceutical or cosmetic or nutritional composition comprising same | Human Necessities | 2 | Expired |
| US8053003B2 | Use of a plant oil product as an agent for increasing the synthesis of skin lipids | Human Necessities | 2 | Active |
| US8586107B2 | Schisandra sphenanthera fruit extract and cosmetic, dermatological, and nutraceutical compositions comprising same | Human Necessities | 2 | Active |
| US8231916B2 | Use of a rice protein hydrolysate as pigmenting active principle | Human Necessities | 1 | Active |
| US8734865B2 | Lupin total extract consisting of a lupin sugar extract and a lupin peptide extract, method for the production and use thereof | Human Necessities | 1 | Active |
| US7511010B2 | Pharmaceutical or cosmetic composition and use of a PKC inhibitor with an MMP inhibitor for inhibiting Langerhans' cell migration | Human Necessities | 1 | Expired |
| US10175230B2 | Use of biomarkers for evaluating the effectiveness of active ingredients | Physics | 1 | Active |
| US7863472B2 | Process for producing refined avocado oil rich in triglycerides, and oil obtainable by said process | Human Necessities | 1 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.